Sentence examples for monitoring burden from inspiring English sources

They worry that the registry would create an overwhelming monitoring burden and that it uses crude means of assessing the likelihood that offenders might repeat their crimes.

Surveillance systems for monitoring burden of disease and resistance patterns are required.

Considerable efforts including leadership, consensus building and resources are required to improve the standards of monitoring burden of disease.

We need innovations in monitoring burden of cause-specific mortality; in monitoring its attendant risk factors; and in monitoring and verifying the actual coverage of required health system responses.

The reasons for this remain unclear but may be due in part to the increased requirements for monitoring, burden of comorbidity, cognitive deficit, and polypharmacy in the elderly [ 4].

Although the 'antithrombotics in AF' topic generated considerable work for little change, it was highly valued by two practices because it identified a small number of patients who could stop warfarin, which mattered given the treatment and monitoring burden this drug imposes on patients and practices.

Herein, we report synthesis and characterization of (E -5- 2- 6- 2-[18F]-fluoroethoxy -benzo[d]thiazol-2-yl)vinyl)-N,N-dimE -5- 2- 6- 2-[18F]-fluoroethoxy -benzo[d]thiazol-2-yl-7B), and pE -5- 2- 6- 2-[18F]-fluoroethoxy -benzo[d]thiazol-2-ylntial to sE -5- 2- 6- 2-[18F]-fluoroethoxy -benzo[d]thiazol-2-ylitoring plaquE -5- 2- 6- 2-[18F]-fluoroethoxy -benzo[d]thiazol-2-yl

Monitoring the burden of IPD in the United States is needed to continue to assess the efficacy of the PCV-7 vaccine as well as the efficacy of newer, more extensive valent PCVs.

Unlike PSA, previous reports have suggested that MSMB levels are unaffected by hormone ablation therapy frequently used in prostate cancer treatment and we need to determine if MSMB might be useful in monitoring disease burden in patients undergoing various forms of treatment [2], [3], [4].

Up-to-date clinical recommendations will support approaches to monitoring iron burden and initiating chelation therapy in NTDT patients.

Therefore, the use of ctDNA has been proposed as a biomarker for monitoring tumor burden and treatment response.